Skip to main content
VMD
NASDAQ Industrial Applications And Services

President Michael Moore Sells Over $1.2 Million in Company Stock Amidst Recent Share Repurchase Authorization

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Medical Device Stocks · Healthcare
Sentiment info
Negative
Importance info
8
Price
$8.63
Mkt Cap
$336.229M
52W Low
$5.93
52W High
$10.06
52W Position info
46% above low
Off High info
14% below high
Rel. Volume info
3.0× avg
Market data snapshot near publication time

VMD sits 46% above its 52-week low of $5.93 on elevated volume (3.0× avg).

Summary

Viemed Healthcare's President, Michael Moore, sold 136,802 shares for $1,237,976, following recent Form 144 filings and occurring shortly after the company authorized a share repurchase program.


Key Events · Ownership and Investor Activity · VMD

  • President Sells Significant Stake

    Michael Moore, President of Viemed Healthcare, sold 136,802 common shares across three transactions between March 18th and March 20th, totaling $1,237,976.

  • Follows Recent Intent-to-Sell Filings

    These sales align with Form 144 filings from March 19th and 20th, which indicated an officer's intent to sell 40,232 and 65,000 shares, respectively, matching the reported transaction quantities.

  • Conflicting Signals with Share Repurchase

    The insider selling occurs just days after Viemed Healthcare announced a new share repurchase program on March 16th, presenting a mixed message to the market regarding the company's valuation and capital strategy.


Analysis · VMD · Industrial Applications And Services

Viemed Healthcare's President, Michael Moore, has reported the sale of 136,802 shares totaling over $1.2 million. This transaction, executed between March 18th and March 20th, follows recent Form 144 filings indicating an intent to sell by an officer, with specific share counts matching the sales on March 19th and 20th. The timing of this significant insider sale is notable as it occurs shortly after the company authorized a new share repurchase program on March 16th, creating conflicting signals regarding management's view of the company's valuation and capital allocation strategy. While the company is buying back shares, a key executive is reducing his stake, which could be interpreted negatively by investors.

At the time of this filing, VMD was trading at $8.63 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $336.2M. The 52-week trading range was $5.93 to $10.06. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

VMD - Latest Insights

VMD
Jun 04, 2026, 4:07 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $9.84
Real-time Price: $12.32 info
Change: +$2.48 (+25%) info
Market Cap: $472.309M info
VMD
May 05, 2026, 5:02 PM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $9.50
Real-time Price: $12.32 info
Change: +$2.82 (+30%) info
Market Cap: $472.309M info
VMD
May 05, 2026, 5:00 PM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $9.62
Real-time Price: $12.32 info
Change: +$2.70 (+28%) info
Market Cap: $472.309M info
VMD
Apr 22, 2026, 4:45 PM EDT
Filing Type: DEF 14A
Importance Score:
8
Price at Filing: $9.51
Real-time Price: $12.32 info
Change: +$2.81 (+30%) info
Market Cap: $472.309M info
VMD
Mar 20, 2026, 4:15 PM EDT
Filing Type: 144
Importance Score:
7
Price at Filing: $8.63
Real-time Price: $12.32 info
Change: +$3.69 (+43%) info
Market Cap: $472.309M info